Pathogenesis, Diagnosis, and Treatment of Prostate Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 18
Special Issue Editor
Interests: medical imaging; molecular imaging; PET/CT; theranostics; cancer imaging
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Prostate cancer is one of the most common malignancies among men and remains a significant clinical challenge due to its heterogeneous nature and evolving therapeutic landscape. This Special Issue seeks to compile high-impact contributions addressing the full continuum of this disease—from molecular mechanisms driving tumorigenesis to state-of-the-art strategies for diagnosis and therapy.
Advances in molecular imaging, particularly positron emission tomography/computed tomography (PET/CT), and the advent of theranostic radiopharmaceuticals have significantly enhanced our ability to detect, characterize, and treat prostate cancer. Radiology and nuclear medicine now play pivotal roles not only in staging and restaging but also in delivering targeted radionuclide therapies that improve patient outcomes. This Special Issue aims to explore both foundational and translational research, including radiogenomics, biomarkers, innovative imaging techniques, and emerging therapeutics.
We welcome original research articles, clinical studies, and comprehensive reviews that focus on pathobiology, precision diagnostics, and therapeutic innovations in prostate cancer. Together, these contributions will provide a platform for advancing personalized and effective management of this complex disease.
Dr. Sara Harsini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- molecular imaging
- PET/CT
- PSMA (prostate-specific membrane antigen)
- theranostics
- radiopharmaceutical therapy
- diagnosis and staging
- radiology
- targeted therapy
- tumor microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
